Dr. Rutter is Chairman and CEO of Synergenics, LLC, Chairman Emeritus of Chiron Corporation and Herzstein Professor of Biochemistry Emeritus at the University of California, San Francisco (UCSF).
Dr. Rutter previously served as a founder and Chairman of Chiron Corporation and member of the Board of Director of Ciba-Greigy/Novartis. He was instrumental in building Chiron into a global biotech power house. In his academic career, Dr. Rutter was chairman of the Department of Biochemistry and Biophysics at the University of California, San Francisco and helped develop UCSF into a preeminent scientific institution. The department played a key role in developing recombinant DNA technology and genetic engineering.
Dr. Rutter has published more than 380 scientific articles and holds more than 25 patents.
In 1999, Dr. Rutter founded Synergenics, LLC, which operates a consortium of commonly-owned but independent biotech companies offering an innovative and cost-effective approach to start-ups in the life sciences industry. Synergenics companies include: iMetrikus, Epitomics, Humabs, ReLia Diagnostic Systems, Synco-BioPartners, Ventria BioSciences, Investigen, Pathologica, Picobella, Poetic Genetics and Synamem.
